Prostate Cancer - Results from #26840

Prostate cancers detected by saturation repeat biopsy impairs the Partin tables' accuracy to predict final pathological stage - Abstract December 16, 2011

Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤ 10 ng/mL - Abstract December 16, 2011

Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy - Abstract December 16, 2011

Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies - Abstract December 16, 2011

Physician social networks and variation in prostate cancer treatment in three cities - Abstract December 16, 2011

Screening for prostate cancer by digital rectal examination and PSA determination in Senegal - Abstract December 16, 2011

The relationship between prostate volume and prostate-specific antigen variability: Data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program - Abstract December 16, 2011

Benefits, barriers, sources of influence, and prostate cancer screening among rural men - Abstract December 16, 2011

PS2-25:Prostate cancer screening: Benefits, barriers and conflicting information - Abstract December 15, 2011

Prostate cancer in a young adult : A case report - Abstract December 15, 2011

Usefulness of MRI prior to prostate needle biopsy in PSA gray zone - Abstract December 15, 2011

The dosimetric effect of mixed-energy IMRT plans for prostate cancer - Abstract December 15, 2011

Increased risk of cancer among gout patients: A nationwide population study - Abstract December 15, 2011

Metastatic prostate carcinoma mimicking primary anal cancer - Abstract December 15, 2011

Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men - Abstract December 15, 2011

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial - Abstract December 15, 2011

High dose brachytherapy as monotherapy for intermediate risk prostate cancer - Abstract December 14, 2011

The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population - Abstract December 14, 2011

Utilization trends at a multidisciplinary prostate cancer clinic: Initial 5-year experience from the Duke Prostate Center - Abstract December 14, 2011

Atrophy of the tongue as the presenting feature of metastatic prostate cancer - Abstract December 14, 2011

Page 1343 of 1447